Clinical approach of cushing syndrome resulting from ACTH-producing metastatic neuroendocrine tumor

Endocrinologist

Volumn 15, Issue 6, 2005, Pages 401-404

  Teves, Denise Angelica ^a,b  

^a CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

Chemoembolization; Ectopic Cushing; Treatment

Indexed keywords

CORTICOTROPIN; HYDROCHLOROTHIAZIDE; HYDROCORTISONE; INSULIN; ISOPHANE INSULIN; KETOCONAZOLE; LABETALOL; LIVER ENZYME; METYRAPONE; MITOTANE; OCTREOTIDE; PENTETREOTIDE; QUINAPRIL; SOMATOSTATIN RECEPTOR; SPIRONOLACTONE;

ABDOMINAL PAIN; ADRENALECTOMY; AGED; ANKLE EDEMA; ARTICLE; BRONCHUS CARCINOID; CASE REPORT; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; CORTICOTROPIN BLOOD LEVEL; CUSHING SYNDROME; DEXAMETHASONE SUPPRESSION TEST; DIABETES MELLITUS; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HEPATIC ARTERY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERTENSION; LIVER METASTASIS; LUNG ADENOCARCINOMA; LUNG NODULE; LYMPHADENOPATHY; MEDIASTINUM LYMPH NODE; MOON FACE; MORBIDITY; MYOPATHY; NEUROENDOCRINE TUMOR; PLEURA; PNEUMONIA; REMISSION; SEPSIS; SYMPTOMATOLOGY; TREATMENT OUTCOME; TREATMENT RESPONSE; WEIGHT GAIN;

EID: 33748601201     PISSN: 10512144     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ten.0000188475.05398.09     Document Type: Article

References (32)

1. Torpy DJ, Mullen N, Ilias I, et al. Association of hypertension and hypokalemia with Cushing's syndrome caused by ectopic ACTH secretion. Ann N Y Acad Sci. 2002;970:134-144.
2. Howlwtt TA, Drury PL, Perry L, et al. Diagnosis and management of ACTH dependent Cushing's syndrome: comparison of features of ectopic and pituitary ACTH production. Clin Endocrinol (Oxf). 1986;24:699-713.
3. Ulick S, Wang JZ, Blumenfeld JD, et al. Cortisol inactivation overload: a mechanism of mineralocorticoid hypertension in the ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab. 1992;74:963-967.
4. Walker BR, Campbell JC, Fraser R, et al. Mineralocorticoid excess inhibition of 11 beta-hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome. Clin Endocrinol (Oxf). 1992;37:481-482.
5. Schambelan M, Slaton PE, Biglieri EGH. Mineralocorticoid production in hyperadrenocorticism: role in pathogenesis of hypokalemic alkalosis. Am J Med. 1971;51:299-303.
6. Etxabe J, Vazquez JA. Morbidity and mortality in Cushing's disease: an epidemiological approach. Clin Endocrinol (Oxf). 1994;40:479-484.
7. Fallo F, Paoletta A, Tona F, et al. Response of hypertension to conventional antihypertensive treatment and/or steroidogenesis inhibitors in Cushing's syndrome. J Intern Med. 1993;234:595-598.
8. Saruta T, Suzuki H, Handa M, et al. Multiple factors contribute to the pathogenesis of hypertension in Cushing's syndrome. J Clin Endocrinol Metab. 1986;62:275-279.
9. Ross EJ, Linch DC. Cushing's syndrome-killing disease: discrimination value of signs and symptoms aiding early diagnosis. Lancet. 1982;2:646-649.
10. Blund SB, Sandler LM, Burrin JM, et al. An evaluation of the distinction of ectopic and pituitary ACTH dependent Cushing's syndrome by clinical features, biochemical tests and radiological findings. QJM. 1990;77:1113-1133.
11. Liddle GW. Tests of pituitary-adrenal suppressibility in the diagnosis of Cushing's syndrome. J Clin Endocrinol Metab. 1960;20:1539-1552.
12. Liddle GW, Nicholson WE, Island DP, et al. Clinical and laboratory studies of ectopic humoral syndromes. Recent Prog Horm Res. 1969;25:283-305.
13. Malchoff CD, Orth DN, Abboud C, et al. Ectopic ACTH syndrome caused by a bronchial carcinoid tumor responsive to dexamethasone, metyrapone, and corticotrophin-releasing factor. Am J Med. 1988;84:760-764.
14. Schteingardt De, Lloyd RV, Akil H, et al. Cushing's syndrome secondary to ectopic corticotrophin releasing hormone-adrenocorticotropin secretion. J Clin Endocrinol Metab. 1986;63:770-775.
15. Leinung M, Young W Jr, Whitaker MD, et al. Diagnosis of corticotrophin-producing bronchial carcinoid tumors causing Cushing's syndrome. Mayo Clin Proc. 1990;65:1314-1321.
16. Aron DC, Flindling JW, Fitzgerald PA, et al. Cushing's syndrome. Problems in management. Endocrinol Rev. 1982;3:229-244.
17. Mc Caughan BC, Martini N, Ains MS. Bronchial carcinoids. J Thorac Cardiovasc Surg. 1985;89:931.
18. Bower BF, Gordon GS. Hormonal effects of neuroendocrine tumors. Ann Rev Med. 1965;16:83-118.
19. Okike N, Bernatz PE, Woolner LB. Carcinoid tumors of the lung. Ann Thorac Surg. 1976;2:270.
20. Grote TH, Macon WR, Davis B, et al. Atypical carcinoid of the lung. A distinct clinicopathological entity. Chest. 1988;93:370.
21. Cerdena P, Eckhauser FE, Kealey GP. Cushing's syndrome secondary to bronchial carcinoid secretion of ACTH. A review. Am Surg. 1993;59:438-442.
22. Jex RK, VanHeesden JA, Carpenter K, et al. Ectopic ACTH syndrome: diagnostic and therapeutic aspects. Am J Surg. 1985;149:276.
23. Deleted in proof.
24. Fernandez-Fernandez F, Halperin I, Manzanares JM, et al. Localization and postoperative follow up of a bronchial carcinoid tumor causing Cushing's syndrome by I111-DTPA labeled octreotide scintigraphy. J Endocrinol Invest. 1997;20:327-330.
25. Kwekkeboom DJ, Krenning EP, Baker WH, et al. Somatostatin analogue scintigraphy in carcinoid tumours. Eur J Nucl Med. 1993;20:283.
26. Torpy, DJ, Chen CC, Mullen JL, et al. Lack of utility of (111) Inpentetreotide scintigraphy in localizing ectopic ACTH producing tumors: follow-up of 18 patients. J Clin Endocrinol Metab. 1999;84:1186-1192.
27. Granberg D, Sundin A, Tiensuu E, et al. OctreoScan in patients with bronchial carcinoid tumors. Clin Endocrinol. 2003;59:793-799.
28. Phlipponeau M, Nocaudie M, Epelbaum J, et al. Somatostatin analogs for the localization and preoperative treatment of an adrenocorticotropin-secreting bronchial carcinoid tumor. J Clin Endocrinol Metab. 1994;78:20-24.
29. Nieman LK. Medical therapy of Cushing's disease. Pituitary. 2002;5:77-82.
30. Lips CJ, Lentjes EG, Hoppener JW, et al. The spectrum of carcinoid tumours and carcinoid syndromes. Ann Clin Biochem. 2003;40:612-627.
31. Roche A, Girish BV, de Baere T, et al. Prognostic factors for chemoembolization in liver metastasis from endocrine tumors. Hepatogastroenterology. 2004;51:1751-1756.
32. Gupta S, Yao JC, Ahrar K, et al. Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the MD Anderson experience. Cancer J. 2003;9:261-267.